Atrioventricular valve regurgitation (AVVR) is a significant issue for many living with congenital heart disease (CHD). It occurs when the heart's atrioventricular valves—mitral and tricuspid—do not close properly, allowing blood to flow backward. This can strain the heart, leading to symptoms such as fatigue, shortness of breath, and swelling in the legs and abdomen.
One of the toughest parts about treating AVVR, especially in babies is the size of the valves. Right now, there is no suitable option for atrioventricular valves smaller than 15mm. These tiny valves are often found in infants and young children, making treatment especially tricky. Surgical options like valve repair or replacement are often not possible for these very small valves, and there are not many, if any suitable prosthetic valves available in such small sizes. There is a lack of suitable prosthetic valves for such small sizes, complicating treatment efforts.
This lack of options highlights the urgent need for more research and innovation in pediatric cardiology. Community support is crucial in the battle against congenital heart disease. By raising awareness, advocating for research funding, and supporting families dealing with AVVR, we can work towards better solutions and improved outcomes for all CHD babies.
𝐀𝐝𝐯𝐨𝐜𝐚𝐜𝐲 𝐛𝐫𝐢𝐧𝐠𝐬 𝐚𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬.
𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐛𝐫𝐢𝐧𝐠𝐬 𝐟𝐮𝐧𝐝𝐢𝐧𝐠.
𝐅𝐮𝐧𝐝𝐢𝐧𝐠 𝐛𝐫𝐢𝐧𝐠𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡.
𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐛𝐫𝐢𝐧𝐠𝐬 𝐡𝐨𝐩𝐞.
To learn more or get involved, please visit our website or contact us directly.